Groffik, A.; Mueller-Brenne, T.; Rudolph, B. et al.
Long-Term Response to Vemurafenib Therapy in Patients with metastatic malignant MelanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 11. H. 9. 2013 S. 908-908
Mitzel, H.; Grabbe, S.; Loquai, C.
Longterm Tumor Remission after Administration of Vemurafenib for a total of 8 DaysJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 11. H. 9. 2013 S. 952-952
Schmidt, T.; Lorenz, N.; Raker, V. et al.
Low zone tolerance protects from Th1/Th17-mediated colitisEXPERIMENTAL DERMATOLOGY. Bd. 22. H. 3. 2013 S. E2-E2
Staubach, Petra; Metz, Martin
Magistral formulations and pruritus therapy - What is established, what is confirmed, what is new?JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 11. H. 11. 2013 S. 1049-1056
Pflugfelder, Annette; Kochs, Corinna; Blum, Andreas et al.
Malignant Melanoma S3-Guideline "Diagnosis, Therapy and Follow-up of Melanoma"JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 11. 2013 S. 1-116
Loquai, C.
Management of Side Effects during Treatment with CTLA-4 AntibodiesJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 11. 2013 S. 52-52
Steinbrink, K.
Mechanisms of innate Immunity in allergic Contact Dermatitis and its clinical SignificanceJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 11. 2013 S. 34-35
Hoyermann, A.; Hahn, S. A.; Satoh, K. et al.
Melanoma cells prevent effector cell responses by mimicking inhibitory mechanisms of human regulatory T cellsJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 11. H. 9. 2013 S. 902-903
Mays, Lauren E.; Ammon-Treiber, Susanne; Mothes, Benedikt et al.
Modified Foxp3 mRNA protects against asthma through an IL-10 dependent mechanismJOURNAL OF CLINICAL INVESTIGATION. Bd. 123. H. 3. 2013 S. 1216-1228
Jolivel, Valerie; Lüssi, Felix; Masri, Joumana et al.
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosisBrain. Bd. 136. H. 4. Oxford: Oxford Univ. Press 2013 S. 1048 - 1066